Japanese Pharmacology and Therapeutics
SJR0.119
JP
JPJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.119 | Q4 | 6.8% | |
| 2024 | — | — | 0.102 | Q4 | 3.2% | |
| 2023 | — | — | 0.120 | Q4 | 17.0% | |
| 2022 | — | — | 0.137 | Q4 | 25.5% | |
| 2021 | — | — | 0.115 | Q4 | 21.6% | |
| 2020 | — | — | 0.127 | Q4 | 14.4% | |
| 2019 | — | — | 0.134 | Q4 | 23.5% | |
| 2018 | — | — | 0.157 | Q4 | 24.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
0386-3603
country
JPcoverage
1981-2026